SEC Form 4 · accession 0001225208-15-014160
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Leonard Baker Jr.
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F2,F1 | $6.55 | Jun 18, 2015 | A | 30,000 | A | — | Jun 18, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Exercisable with respect to 8.334% of the total option shares on each monthly anniversary of June 18, 2015, with the vesting of all remaining shares to occur on or before the date of Corcept's 2016 Annual Meeting of Stockholders.
- F2The reporting person shares pecuniary interest in these shares with other individuals pursuent to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.